1-4 of 4
Arturo Vega
Close
Sort by
Journal Articles

Natural History, Risk Factors and Prognostic Impact of Graft-Versus-Host Disease Classified According to the National Institute of Health Criteria in Patients Receiving Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Theis H Terwey, Arturo Vega-Ruiz, Philipp G. Hemmati, Peter Martus, Ekkehart Dietz, Lam G Vuong, Philipp D le Coutre, Bernd Dörken, Renate Arnold
Journal: Blood
Blood (2010) 116 (21): 899.
https://doi.org/10.1182/blood.V116.21.899.899
Published: 2010
Journal Articles

Pre-Transplant Risk-Assessment for Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplants.

Philipp G. Hemmati, MD, Theis H. Terwey, MD, Philipp le Coutre, MD, Gero Massenkeil, MD, Lam G Vuong, PhD, Christian Jakob, MD, Arturo Vega, MD, Bernd Dörken, MD, Renate Arnold, MD
Journal: Blood
Blood (2009) 114 (22): 2302.
https://doi.org/10.1182/blood.V114.22.2302.2302
Published: 2009
Journal Articles

Incidence and Clinical Characteristics of Chronic Graft Versus Host Disease (cGVHD) According to the National Institutes of Health (NIH) Criteria in Patients Transplanted for Acute Myeloid Leukemia (AML).

Arturo Vega, Peter Martus, Theis Terwey, Christian Jakob, MD, Lam G Vuong, Philipp Hemmati, Philipp D. le Coutre, MD, Renate Arnold, MD
Journal: Blood
Blood (2009) 114 (22): 4639.
https://doi.org/10.1182/blood.V114.22.4639.4639
Published: 2009
Journal Articles

Better Molecular Response to Imatinib for Patients (pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Carrying the b3a2 Transcript Compared to b2a2.

Arturo Vega-Ruiz, Hagop Kantarjian, Jenny Shan, William Wierda, Jan Burger, Srdan Verstovsek, Guillermo Garcia-Manero, Jorge Cortes
Journal: Blood
Blood (2007) 110 (11): 1939.
https://doi.org/10.1182/blood.V110.11.1939.1939
Published: 2007